BridgeBio Pharma, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
BBIO on Nasdaq
Location
3160 Porter Dr., Suite 250, Palo Alto, California

Insiders trading volume in the past year

BridgeBio Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viking Global Investors Lp 10%+ Owner $954 M -$52.5 M -5.22% Jul 18, 2023
Neil Kumar CEO and President, Director $223 M -$2.97 M -1.31% May 16, 2024
Charles J. Homcy Director $45.8 M Jun 21, 2024
Frank Mccormick Director $34.4 M -$4.21 M -10.9% Jun 21, 2024
Brian C. Stephenson Secretary, Treasurer & CFO $5.79 M -$1.31 M -18.4% May 16, 2024
Richard H. Scheller Director $2.42 M Feb 16, 2023
Brent L. Saunders Director $668 K Jun 22, 2022
Randal W. Scott Director $282 K -$389 K -58% Jun 21, 2024
Hannah Valantine Director $196 K -$413 K -67.8% Jun 21, 2024
Ronald J. Daniels Director Jun 21, 2024
James C. Momtazee Director Jun 21, 2024
Andrea Ellis Director Jun 21, 2024
Douglas A. Dachille Director Jun 21, 2024
Fred Hassan Director Jun 21, 2024
Andrew Lo Director Jun 21, 2024
Eric Aguiar Director Jun 21, 2024
Jennifer E. Cook Director Jun 21, 2024
Ali J. Satvat Director Jun 21, 2024

Recent Insider Transactions by Companies or Individuals for BridgeBio Pharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership